Abstract
Almost 10 years after the discovery of Orphanin FQ / Nociceptin (OFQ/N) a large number of synthetic small molecule agonists and antagonists have been developed and tested in various physiological assays. Together with the academic work on the physiological functions of OFQ/N, we now have compelling evidence that this neuropeptide system might represent a valuable target for the development of drugs treating a variety of psychiatric disorders. Most prominently, the anti-stress and anxiolytic effects of OFQ/N agonists have been investigated although clinical trials have not yet been launched. Other possible applications of OFQ/N agonists and antagonists include treatment of depression, anorexia and rewarding aspects of drug addiction. This paper will summarize current developments and highlight the scientific achievements that have been made to elucidate the functions of OFQ/N with respect to psychiatric disorders.
Keywords: Orphanin FQ, nociceptin, neuropeptide, anxiety, stress, depression, obesity, anorexia, drug abuse, reward
CNS & Neurological Disorders - Drug Targets
Title: The Orphanin FQ / Nociceptin Receptor as a Novel Drug Target in Psychiatric Disorders
Volume: 5 Issue: 2
Author(s): Rainer K. Reinscheid
Affiliation:
Keywords: Orphanin FQ, nociceptin, neuropeptide, anxiety, stress, depression, obesity, anorexia, drug abuse, reward
Abstract: Almost 10 years after the discovery of Orphanin FQ / Nociceptin (OFQ/N) a large number of synthetic small molecule agonists and antagonists have been developed and tested in various physiological assays. Together with the academic work on the physiological functions of OFQ/N, we now have compelling evidence that this neuropeptide system might represent a valuable target for the development of drugs treating a variety of psychiatric disorders. Most prominently, the anti-stress and anxiolytic effects of OFQ/N agonists have been investigated although clinical trials have not yet been launched. Other possible applications of OFQ/N agonists and antagonists include treatment of depression, anorexia and rewarding aspects of drug addiction. This paper will summarize current developments and highlight the scientific achievements that have been made to elucidate the functions of OFQ/N with respect to psychiatric disorders.
Export Options
About this article
Cite this article as:
Reinscheid K. Rainer, The Orphanin FQ / Nociceptin Receptor as a Novel Drug Target in Psychiatric Disorders, CNS & Neurological Disorders - Drug Targets 2006; 5 (2) . https://dx.doi.org/10.2174/187152706776359628
DOI https://dx.doi.org/10.2174/187152706776359628 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Targeting Signal Transduction Pathways in the Treatment of Mood Disorders: Recent Insights into the Relevance of the Wnt Pathway
CNS & Neurological Disorders - Drug Targets Enhanced Mechanical Properties of Rabbit Flexor Tendons in Response to Intratendinous Injection of Adipose Derived Stromal Vascular Fraction
Current Stem Cell Research & Therapy NPY and Receptors in Immune and Inflammatory Diseases
Current Topics in Medicinal Chemistry Recent Developments in the Medicinal Chemistry of NK2 Receptor Antagonists
Current Topics in Medicinal Chemistry Socio-economic Aspects of Alzheimer's Disease
Current Alzheimer Research Prevention of Lymphocyte Neurotoxic Effects by microRNA Delivery
MicroRNA Regenerative Dendritic Spikes and Synaptic Plasticity
Current Neurovascular Research Erratum: Therapeutic Approaches to Modulating Glutathione Levels as a Pharmacological Strategy in Alzheimer’s Disease
Current Alzheimer Research Role of Metalloproteinases in Tendon Pathophysiology
Mini-Reviews in Medicinal Chemistry Role of Altered Structure and Function of NMDA Receptors in Development of Alcohol Dependence
Current Neuropharmacology Meet Our Editorial Board Member
Current Medicinal Chemistry Dangerous Liaisons: Tau Interaction with Muscarinic Receptors
Current Alzheimer Research The Recent Advance of Ramberg-Bäcklund Reaction
Mini-Reviews in Organic Chemistry CB1 Cannabinoid Receptors and their Associated Proteins
Current Medicinal Chemistry Obstructive Sleep Apnea and Atrial Arrhythmogenesis
Current Cardiology Reviews Cancer and Phase II Drug-Metabolizing Enzymes
Current Drug Metabolism Oral Immune Regulation: A New Mode of Therapy Against Chronic Viral Infections
Recent Patents on Anti-Infective Drug Discovery Phytoconstituents and their Possible Mechanistic Profile for Alzheimer’s Disease – A Literature Review
Current Drug Targets Cost-Effectiveness of Interventions to Enhance Medication Adherence in Psychiatric Patients: A Systematic Review
Current Clinical Pharmacology Reducing Gabaergic Inhibition Restores Cognitive Functions in a Mouse Model of Down Syndrome
CNS & Neurological Disorders - Drug Targets